Meda Ab (MDABY) 17.5000 $MDABY Mylan Announces Pricing

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Meda Ab (MDABY) 17.5000 $MDABY

Mylan Announces Pricing of Senior Notes
PR Newswire - Tue May 31, 4:24PM CDT
Mylan N.V. (NASDAQ, TASE: MYL) today announced the pricing of a private placement of $6.5 billion aggregate principal amount of senior notes, comprised of $1.0 billion aggregate principal amount of 2.50% senior notes due 2019 at an issue price of 99.888%, $2.25 billion aggregate principal amount of 3.15% senior notes due 2021 at an issue price of 99.884%, $2.25 billion aggregate principal amount of 3.95% senior notes due 2026 at an issue price of 99.231% and $1.0 billion aggregate principal amount of 5.25% senior notes due 2046 at an issue price of 99.984%. Mylan intends to use the net proceeds from the offering of notes to finance its previously announced public offer (the "Offer" to acquire all of the outstanding shares of Meda AB (publ.) (the "Meda Acquisition" , to repay, prepay, redeem or otherwise refinance its or any of its subsidiaries' indebtedness (including that of Meda and its subsidiaries) (the "Refinancing" and to pay costs associated with the Meda Acquisition and the Refinancing, including non-periodic fees, costs and expenses, stamp registration and other taxes. Upon completion of the offering of the notes, Mylan intends to reduce the commitments under its Bridge Credit Agreement, dated as of Feb. 10, 2016, in an amount equal to the aggregate net proceeds from the offering of the notes. Subject to customary closing conditions, the sale of the notes is expected to close on or about June 9, 2016.
MYL: 44.13 (+0.43)

MEDA: Interim Report, January-March 2016
BusinessWire - Tue May 03, 1:18AM CDT
Regulatory News:

MEDA: Invitation to teleconference for analysts, investors and media
BusinessWire - Tue Apr 26, 6:12AM CDT
Regulatory News:

Meda AB (publ) AGM bulletin
BusinessWire - Thu Apr 14, 2:15PM CDT
Regulatory News:

Business Highlights
By The Associated Press - AP - Wed Feb 10, 5:45PM CST
___
WFM: 33.70 (+0.42), BUD: 128.03 (+0.84), TGT: 70.65 (+0.56), WMT: 73.50 (-0.03), ODP: 3.31 (+0.05)

Statement by the Board of Directors of Meda in relation to the public offer by Mylan
BusinessWire - Wed Feb 10, 5:29PM CST
Regulatory News:

Mylan to buy Sweden's Meda AB for $7.2 billion
AP - Wed Feb 10, 4:42PM CST
NEW YORK (AP) — Drugmaker Mylan says it will buy Meda AB of Sweden for $7.2 billion in cash and stock, and says the move will help it enter new markets.
ABT: 41.84 (+0.48), MYL: 44.13 (+0.43)

MEDA: Year-end Report, January-December 2015
BusinessWire - Wed Feb 10, 4:09PM CST
Regulatory News:

MEDA: Invitation to Teleconference for Analysts, Investors and Media
BusinessWire - Thu Feb 04, 4:47AM CST
Meda AB (STO:MEDAA) (Pink Sheets:MDABY)

MEDA completes divestment of Euromed manufacturing unit in Spain
M2 - Thu Dec 31, 5:21AM CST
Meda AB (STO:MEDAA) (Pink Sheets:MDABY) on Wednesday announced the completion of the divestment of its manufacturing unit Euromed in Spain.

MEDA: Divestment of Manufacturing Unit Euromed in Spain Completed
BusinessWire - Wed Dec 30, 1:09AM CST
Regulatory News:

Muscle Spasm Global Clinical Trials Review, H2, 2015 - Analysis & Technologies
M2 - Mon Dec 14, 5:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/gsz2s9/muscle_spasm) has announced the addition of the "Muscle Spasm Global Clinical Trials Review, H2, 2015" report to their offering. This clinical trial report, Muscle Spasm Global Clinical Trials Review, H2, 2015" provides an overview of Muscle Spasm clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Spasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database. Key Topics Covered: - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Benefits of this Report: - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level Companies Mentioned: - Themis Medicare Ltd. - Inventia Healthcare Private Limited - Allergan Plc - Flex Pharma, Inc. - Navipharm Co., Ltd - Meda AB - Ipsen S.A. - Eisai Co., Ltd. - Dr. Reddy's Laboratories Limited - Avigen, Inc. For more information visit http://www.researchandmarkets.com/research/gs...scle_spasm
AGN: 239.68 (+1.67), FLKS: 11.16 (+0.31)

Update on License Agreement between Meda and Valeant
BusinessWire - Mon Nov 16, 12:12AM CST
Regulatory News:

Meda reports profit after tax of SEK163m in Q3 2015
M2 - Fri Nov 06, 3:33AM CST
Meda AB (STO:MEDAA) (Pink Sheets:MDABY) on Thursday reported profit after tax of SEK163m, or EPS of SEK0.45, for the third quarter of 2015, from July 2015 to September 2015.

MEDA: Interim Report, January-September 2015
BusinessWire - Thu Nov 05, 1:19AM CST
Regulatory News:

Meda appoints members of nomination committee
M2 - Wed Oct 14, 5:45AM CDT
Meda AB (STO:MEDAA)(Pink Sheets:MDABY) announced on Tuesday that members of its nomination committee are Bert Ake Eriksson, the committee's chairman; Stena Sessan, from Rederi AB; Sigieri Diaz Pallavicini, from Fidim S.r.l; Evert Carlsson, from Swedbank Robur Funds; Elisabet Jamal Bergstrom, from Handelsbanken Fonder and Martin Svalstedt, Meda's chairman of the board of directors of the company.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 232

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 187

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 302

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 119

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 169

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Community Engagement Takes Center Stage at SAS Championship

Updated Category News Views 196

Community Engagement Takes Center Stage at SAS Championship Community initiative supports local teachers, sparks student interest in technology Teachers often face financial challenges covering classroom needs, especially in STEM (science, technology, engineering, and math) education, which is critical for preparing students for a tech-driven future. To alleviate this,...

Continue Reading
Explore Yaber's Next-Gen Projectors Unveiled at CES 2025

Updated Category News Views 305

Innovative Projectors Unveiled by Yaber at CES 2025 Yaber, renowned for its cutting-edge entertainment projectors, revealed its latest models at the CES 2025 event. Among these, the K300s, L2 Plus, and T2 Series stand out, showcasing incredible advancements in home entertainment technology. These projectors are designed to elevate the viewing experience, whether you're...

Continue Reading
Important Update for UroGen Pharma Investors Ahead of Deadline

Updated Category News Views 188

UroGen Pharma Investors: Key Deadline Approaching Attention UroGen Pharma Ltd. investors! The clock is ticking on an important opportunity that you won't want to miss. The class action lawsuit involving UroGen Pharma (URGN) has reached a crucial stage and if you've been affected, now is the time to act. The deadline for an essential step in the lawsuit is coming up on...

Continue Reading
Enhancing Workplace Safety with Voxel's Innovative Impact Boards

Updated Category News Views 121

Revolutionizing Workplace Safety with AI Insights In today's fast-paced work environment, ensuring safety and operational efficiency is paramount. Voxel, an Applied AI company dedicated to transforming workplace safety, has launched its latest innovation: the Impact Boards. These boards are designed to provide tailored, shift-specific safety insights that enable teams to...

Continue Reading
First Quantum Minerals Expands Senior Notes Offering Leadership

Updated Category News Views 112

First Quantum Minerals Expands Senior Notes Offering In a significant development, First Quantum Minerals Ltd. (TSX: FM) has announced a remarkable $1 billion offering of senior notes, demonstrating its strong standing in the mining industry. The company has increased the original offering amount from $750 million to $1 billion, clearly indicating investor confidence and...

Continue Reading